{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T07:02:46Z","timestamp":1649142166570},"reference-count":18,"publisher":"Societas Neurologica Japonica","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rinsho Shinkeigaku"],"published-print":{"date-parts":[[2013]]},"DOI":"10.5692\/clinicalneurol.53.507","type":"journal-article","created":{"date-parts":[[2013,7,25]],"date-time":"2013-07-25T23:32:15Z","timestamp":1374795135000},"page":"507-512","source":"Crossref","is-referenced-by-count":0,"title":["Neurologic manifestations in rheumatic diseases"],"prefix":"10.5692","volume":"53","author":[{"given":"Atsushi","family":"Kawakami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3663","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) ACR Ad Hoc Committee on Neuruopsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599-608.","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Muscal E, Myones BL. The role of autoantibodies in pediatric neuropsychiatric systemic lupus erythematosus. Autoimmun Rev 2007;6:215-217.","DOI":"10.1016\/j.autrev.2006.08.003"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Stojanovich L, Zandman-Goddard G, Pavlovich S, et al. Psychiatric manifestations in systemic lupus erythematosus. Autoimmun Rev 2007;6:421-426.","DOI":"10.1016\/j.autrev.2007.02.007"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Hirohata S, Kanai Y, Mitsuo A, et al. Accuracy of cerebrospinal fluid IL-6 testing for diagnosis of lupus psychosis. A multicenter retrospective study. Clin Rheumatol 2009;28:1319-1323.","DOI":"10.1007\/s10067-009-1226-8"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Fragoso-Loyo H, Atisha-Fregoso Y, N\u00fa\u00f1ez-Alvarez CA, et al. Utility of interferon-a as a biomarker in central neuropsychiatric involvement in systemic lupus erythematosus. J Rheumatol 2012;39:504-509.","DOI":"10.3899\/jrheum.110983"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) DeGiorgio LA, Konstantinov KN, Lee SC, et al. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 2001;7:1189-1193.","DOI":"10.1038\/nm1101-1189"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Tokunaga M, Saito K, Kawabata D, et al. Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system. Ann Rheum Dis 2007;66:470-475.","DOI":"10.1136\/ard.2006.057885"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Fujikawa K, Kawakami A, Kaji K, et al. Association of distinct clinical subsets with myositis-specific autoantibodies towards anti-155\/140-kDa polypeptides, anti-140-kDa polypeptides, and anti-aminoacyl tRNA synthetases in Japanese patients with dermatomyositis: a single-centre, cross-sectional study. Scan J Rheumatol 2009;38:263-267.","DOI":"10.1080\/03009740802687455"},{"key":"9"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Nakamura H, Eguchi K, Nakamura T, et al. High prevalence of Sj\u00f6gren\u2019s syndrome in patients with HTLV-I associated myelopathy. Ann Rheum Dis 1997;56:167-172.","DOI":"10.1136\/ard.56.3.167"},{"key":"11","unstructured":"11) Nakamura H, Takagi Y, Kawakami A, et al. HTLV-I infection results in resistance toward salivary gland destruction of Sj\u00f6gren\u2019s syndrome. Clin Exp Rheumatol 2008;26:653-655."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Kim SM, Waters P, Vincent A, et al. Sjogren\u2019s syndrome myelopathy: spinal cord involvement in Sjogren\u2019s syndrome might be a manifestation of neuromyelitis optica. Mult Scler 2009;15:1062-1068.","DOI":"10.1177\/1352458509106636"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Kahlenberg JM. Neuromyelitis optica spectrum disorder as an initial presentation of primary Sj\u00f6gren\u2019s syndrome. Semin Arthritis Rheum 2011;40:343-348.","DOI":"10.1016\/j.semarthrit.2010.05.005"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Fujikawa K, Aratake K, Kawakami A, et al. Successful treatment of refractory neuro-Behcet\u2019s disease with infliximab: a case report to show its efficacy by magnetic resonance imaging, transcranial magnetic stimulation and cytokine profile. Ann Rheum Dis 2007;66:136-137.","DOI":"10.1136\/ard.2006.056804"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37:187-192.","DOI":"10.1002\/art.1780370206"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Ramos-Casals M, Brito-Zer\u00f3n P, Mu\u00f1oz S, et al. Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Medicine (Baltimore) 2007;86:242-251.","DOI":"10.1097\/MD.0b013e3181441a68"},{"key":"17","unstructured":"17) Guillevin L, Mouthon L. Tumor necrosis factor-alpha blockade and the risk of vasculitis. J Rheumatol 2004;10:1885-1887."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Fujikawa K, Kawakami A, Hayashi T, et al. Cutaneous vasculitis induced by TNF inhibitors: a report of three cases. Mod Rheumatol 2010;20:86-89.","DOI":"10.3109\/s10165-009-0232-7"}],"container-title":["Rinsho Shinkeigaku"],"original-title":["\u30ea\u30a6\u30de\u30c1\u30fb\u81a0\u539f\u75c5\u3068\u795e\u7d4c\u75be\u60a3"],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T20:06:40Z","timestamp":1621541200000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/clinicalneurol\/53\/7\/53_507\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.5692\/clinicalneurol.53.507","relation":{},"ISSN":["0009-918X","1882-0654"],"issn-type":[{"value":"0009-918X","type":"print"},{"value":"1882-0654","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}